Oleksandra Kutsenko

Fernando de Zarraga MD, is a graduate of the University of Miami Miller School of Medicine. He trained in internal medicine at the University of Miami/Jackson Memorial Hospital and hematology and medical oncology at Jackson Memorial Hospital and the University of Miami Sylvester Comprehensive Cancer center.

Dr de Zarraga has been practicing since 2004, the last 6 years in South Florida at the Miami Cancer Institute, part of Baptist Health of South Florida, selected as one of the top 100 hospitals in the United States. Dr de Zarraga's practice specializes in the care of cancer patients with gastrointestinal and sarcoma malignancies. Dr de Zarraga's interests also include molecular profiling, targeted agents, collaborative approaches, and furthering individualized treatment plans. Dr de Zarraga is also affiliated with Florida International University and the Herbert Wertheim College of Medicine.

Dr de Zarraga is board certified in internal medicine, hematology, and medical oncology.

Dr. Oleksandra Kutsenko is an Interventional Radiologist at Red Rock Radiology and serves as Director of Interventional Radiology for the HCA Healthcare Radiology Residency Program. She is a member of the Society of Interventional Radiology (SIR) Economics Steering Committee and the Interventional Oncology Council. Her contributions in this area earned her the SIR Economics Champion Award in 2024. Dr. Kutsenko also contributes her expertise in interventional oncology as a Board Member for the Las Vegas Market Cancer Governance. A passionate advocate for innovation in medicine, she shares her vision in the TEDx talk, "Believe in Better Medicine."

Doctor Iqbal is an Interventional Radiologist at the Massachusetts General Hospital and serves as the Director for quality & safety for Interventional Radiology. Shams is passionate about finding new techniques to help patients get the best care possible across IR. He developed a new technique for Intraoperative localization of small lung nodule at surgery decreasing morbidity and increasing safety and accuracy. He is the chairman of the “SIR give back program” and helps Interventional Radiology programs across the globe. He is the Leader for SIR Global educational initiative. His basic research is in nanotechnology techniques for early diagnosis of cancers and metastases, focusing on cholangiocarcinoma. He is working on device development, with devices in the pipeline for gastroparesis management by neuromodulation. His overarching goal is to provide good quality Interventional Radiology training and IR care to patients across the globe and find early diagnosis of cancers to prolong patient survival.

Constantino S. Peña, M.D., serves as the Section Head of interventional radiology. He is the medical director of vascular imaging at Baptist Health Miami Cardiac & Vascular Institute.
Dr. Peña earned his bachelor’s and master’s degrees from Stanford University, and his medical degree from Yale University School of Medicine. He completed his residency in diagnostic radiology and a vascular and interventional fellowship in Massachusetts General Hospital in Boston, Massachusetts.
Dr. Peña is a clinical associate professor of radiology at Florida International University Herbert Wertheim College of Medicine. He has presented in numerous national and international meetings as well as participated in multiple clinical trials.
He has served for many professional organizations. He serves as the chair for the Cardiovascular Radiology & Intervention Council of the American Heart Association. He presently serves on the executive council of the Society of Interventional Radiology and was a past Annual Meeting Chair. He has served on several committee on the American Board of radiology and is a Board examiner. He also served on the Radiology Info Committee of the American College of Radiology and Radiological Society of North America and the Society of Interventional Radiology Oncology Service Line.
Dr. Peña is a fellow of the Society of Interventional Radiology, American Heart Association and the Society of Cardiovascular Computed Tomography (CT). He is also a member of the Radiological Society of North America, American College of Radiology, Society of Cardiovascular CT, Iberoamerican Society of Interventional Radiology and the North American Society for Cardiac Imaging.

Dr. Constantinos T. Sofocleous is clinician scientist specializing in interventional oncology, caring for people with cancer. He has been practicing interventional radiology since 1998 and joined the Interventional Radiology Service at Memorial Sloan Kettering in 2002. His expertise include the treatment of primary and metastatic liver and lung cancers using thermal ablation (radiofrequency, microwave, cryoablation) or other non-thermal sources of energy (NanoKnife ® or irreversible electroporation and histotripsy). He also specializes in catheter-directed therapies that treat malignant liver tumors that cannot be removed through surgery or destroyed locally (ablation). He lectures nationally and internationally on topics such as embolization, radio embolization, and ablation of liver tumors — particularly metastases from colorectal cancer in the liver and lungs. His research interest is the assessment, validation, and development of biomarkers and surrogate imaging biomarkers. He was the MSK site primary investigator, of a multi-institutional, RCT Yttrium 90 glass microspheres in addition to standard of care second-line chemotherapy for colorectal liver metastases. He has the Optablate NIH Supported R01 clinical trial. He led the ACCLAIM trial as the global PI. He is currently leading and SIR foundation supported trial to optimize dosimetry for Y90 TARE via post treatment PET guided biopsies. He also explores the immunomodulation effcets of locoregional therapies uisng peripheral and tissue biomrakres. Despite his strong interest in research, Dr. Sofocleous' main focus remains caring for patients.

Adeel Kaiser, M.D., is a board-certified radiation oncologist at Miami Cancer Institute and Director of the Radiopharmaceutical Therapy Program. He has expertise in the treatment of a number of solid tumor malignancies, with a special focus on genitourinary and gastrointestinal cancers. He also has significant experience in proton therapy dating back to 2008, when he served as an assistant professor at Loma Linda University Medical Center, the first clinical proton therapy center in the United States. Dr. Kaiser joined Miami Cancer Institute in 2020 from the University of Maryland Department of Radiation Oncology, where he served as Fellowship Director as well as Director of the Integrative Wellness Program.